Table 3.
Model A1 | Model A2 | Model A3 | Model B1 | Model B2 | Model B3 | |
---|---|---|---|---|---|---|
OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
RAPS, T1 | 1.02 (0.96–1.09) | 1.02 (0.96–1.09) | 1.32 (0.96–1.81) | 1.02 (0.96–1.09) | 1.03 (0.97–1.09) | 1.76 (1.09–2.81)* |
Functional limitations, T1 | 2.4 (1.75–3.28)*** | 2.29 (1.66–3.15)*** | 2.31 (1.68–3.2)*** | 2.41 (1.76–3.3)*** | 2.5 (1.77–3.53)*** | 2.9 (1.9–4.41)*** |
External HCB, T1 | 1.04 (0.99–1.09) | 1.05 (0.99–1.11) | ||||
RAPS*External HCB | 0.99 (0.99–1.00) | |||||
GSE, T1 | 0.89 (0.81–0.98)* | 0.88 (0.8–0.97)** | ||||
RAPS*GSE | 0.98 (0.97–1.00)* | |||||
R square | 0.35 | 0.36 | 0.37 | 0.35 | 0.38 | 0.41 |
Note. RAPS relative accessibility problem score; ADL activities of daily living; HCB housing-related control beliefs; GSE general self-efficacy; OR odds ratio; CI confidence interval
* p-value ≤0.05 level (2-tailed); ** p-value ≤0.01 level (2-tailed); *** p-value ≤0.001 level (2-tailed)